普罗米修斯实验室将在2026年推出新一代血液检测MASH肝病. Prometheus Labs launches next-gen blood test for MASH liver disease in 2026.

普罗米修斯实验室在2026年消化疾病周宣布了新的研究,支持下一代血液检测以改善MASH的诊断,这是影响数百万美国人的肝脏病. Prometheus Laboratories announced new research at Digestive Disease Week 2026 supporting a next-generation blood test to improve the diagnosis of MASH, a liver disease affecting millions of Americans. 该测试旨在更好地识别中度纤维化患者进行治疗,同时排除肝硬化,使用基于间隔的评分方法. The test aims to better identify patients with moderate fibrosis for therapy while ruling out cirrhosis, using an interval-based scoring approach. 普罗米修斯计划在2026年晚些时候推出新测试,以帮助临床医生管理符合治疗条件的患者. Prometheus plans to launch the new test later in 2026 to help clinicians manage treatment-eligible patients.